Journal
CELL
Volume 151, Issue 1, Pages 56-67Publisher
CELL PRESS
DOI: 10.1016/j.cell.2012.08.026
Keywords
-
Categories
Funding
- National Institutes of Health [HG002668, CA146445]
- Swedish Research Council [VR-B0086301]
- American Cancer Society [PF-11-042- 01-DMC]
- Damon-Runyon Cancer Research Foundation
Ask authors/readers for more resources
Elevated expression of the c-Myc transcription factor occurs frequently in human cancers and is associated with tumor aggression and poor clinical outcome. The effect of high levels of c-Myc on global gene regulation is poorly understood but is widely thought to involve newly activated or repressed Myc target genes. We report here that in tumor cells expressing high levels of c-Myc the transcription factor accumulates in the promoter regions of active genes and causes transcriptional amplification, producing increased levels of transcripts within the cell's gene expression program. Thus, rather than binding and regulating a new set of genes, c-Myc amplifies the output of the existing gene expression program. These results provide an explanation for the diverse effects of oncogenic c-Myc on gene expression in different tumor cells and suggest that transcriptional amplification reduces rate-limiting constraints for tumor cell growth and proliferation.
Authors
I am an author on this paper
Click your name to claim this paper and add it to your profile.
Reviews
Recommended
No Data Available